口腔がん治療の世界市場レポート 2025年

口腔がん治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9％で28億6,000万米ドルに成長します。予測期間の成長は、革新的な治療法に対する規制当局の支援、バイオマーカー研究の進歩、治療選択肢の拡大、スクリーニングと早期発見の改善、遠隔医療、遠隔モニタリングなどに起因すると考えられます。予測期間における世界の主な動向には、世界の疫学的変化、規制の変更と承認、認知度の向上と早期発見キャンペーン、患者中心の医療、補助療法などが含まれます。

タバコの消費量の増加が今後の口腔がん治療市場の成長を牽引すると予測されます。タバコは、ニコチアナ・タバカムやニコチアナ属の他の植物の葉から得られるが、有害物質、発がん性物質、ニコチンを含み、口腔がんを含む様々ながんのリスク上昇に関連しています。例えば、2023年12月、英国の政府機関である国民保健サービス（National Health Service）は、2022-23年の喫煙に関連する入院患者数は推定408,700人で、2021-22年の389,800人から4.8％増加したと報告しています。したがって、タバコ消費の増加が口腔がん治療市場の成長を促進しています。

口腔がんの有病率の増加は、口腔がん治療市場を推進する重要な要因になると予想されます。口腔がんは、口腔組織に影響を及ぼす制御不能な細胞増殖と浸潤を特徴とし、病期に応じて外科的切除、放射線療法、化学療法によって治療されるのが一般的です。2022年、米国がん協会は、毎年約54,540件の口腔がんまたは口腔咽頭がんが新たに発生し、毎年約11,580人が死亡していると報告しています。その結果、口腔がんの罹患率の上昇が口腔がん治療市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界口腔がん治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の口腔がん治療市場：成長率分析
• 世界の口腔がん治療市場の実績：規模と成長, 2019-2024
• 世界の口腔がん治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界口腔がん治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の口腔がん治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 口腔扁平上皮がん
• 口腔疣贅がん
• 粘液表皮がん
• 口腔リンパ腫
• 世界の口腔がん治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 放射線治療
• 生物学的療法
• 世界の口腔がん治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射可能
• その他の投与経路
• 世界の口腔がん治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の口腔がん治療市場口腔扁平上皮がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手術
• 放射線治療
• 化学療法
• 標的療法
• 世界の口腔がん治療市場口腔疣贅がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科的切除
• 放射線治療
• 世界の口腔がん治療市場粘表皮がんの種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外科的切除
• 放射線治療
• 化学療法
• 世界の口腔がん治療市場口腔リンパ腫の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 放射線治療
• 免疫療法

第7章 地域別・国別分析

• 世界の口腔がん治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の口腔がん治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 口腔がん治療市場：競合情勢
• 口腔がん治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi-Aventis LLC
• Bristol Myers Squibb
• AstraZeneca plc
• GlaxoSmithKline plc
• Eli Lilly and Company
• C.H. Boehringer Sohn AG & Co. KG.
• Viatris Inc.
• Teva Pharmaceuticals Industries Ltd.
• MD Anderson Cancer Center
• Bausch Health Companies Inc.
• Memorial Sloan Kettering Cancer Center
• Aurobindo Pharma Limited
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 口腔がん治療市場2029：新たな機会を提供する国
• 口腔がん治療市場2029：新たな機会を提供するセグメント
• 口腔がん治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oral cancer treatment encompasses medical interventions and therapies aimed at diagnosing, managing, and potentially curing cancer that develops in the oral cavity or oral tissues. The chosen treatment approach is contingent upon factors such as the type, stage, and location of the cancer, as well as the overall health of the patient.

The primary types of oral cancer treatment are designed for conditions such as oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma, and oral cavity lymphomas. Oral squamous cell carcinoma originates in the squamous cells lining the oral cavity, including the lips, tongue, inner lining of the cheeks, and gums. Various therapeutic modalities include chemotherapy, radiation therapy, and biological therapy, administered through oral, injectable, and other routes. The diverse end users include hospitals, homecare, specialty clinics, and others.

The oral cancer treatment market research report is one of a series of new reports from The Business Research Company that provides oral cancer treatment market statistics, including oral cancer treatment industry global market size, regional shares, competitors with an oral cancer treatment market share, detailed oral cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the oral cancer treatment industry. This oral cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral cancer treatment market size has grown strongly in recent years. It will grow from $2.04 billion in 2024 to $2.2 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to interdisciplinary treatment approaches, screening programs implementation, improvements in palliative care, reconstructive surgery innovations, clinical trial discoveries.

The oral cancer treatment market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to regulatory support for innovative therapies, advancements in biomarker research, expanding therapeutic options, improved screening and early detection, telemedicine and remote monitoring. Major trends in the forecast period include global epidemiological changes, regulatory changes and approvals, rising awareness and early detection campaigns, patient-centric care, adjuvant therapies.

The increasing consumption of tobacco is projected to drive the growth of the oral cancer treatment market in the future. Tobacco, derived from the leaves of Nicotiana tabacum and other plants in the Nicotiana genus, contains harmful substances, carcinogens, and nicotine, which are associated with a heightened risk of various cancers, including oral cancer. For example, in December 2023, the National Health Service, a government department in the UK, reported an estimated 408,700 hospital admissions related to smoking in the 2022-23 period, up from 389,800 in 2021-22, reflecting a rise of 4.8%. Therefore, the rising tobacco consumption is fueling the growth of the oral cancer treatment market.

The growing prevalence of oral cancer is expected to be a key factor propelling the oral cancer treatment market. Oral cancer, characterized by uncontrolled cell growth and invasion affecting oral cavity tissues, is typically treated through surgical resection, radiation therapy, and chemotherapy, depending on the disease's stage. In 2022, the American Cancer Society reported approximately 54,540 new cases of oral cavity or oropharyngeal cancer each year, leading to approximately 11,580 deaths annually. Consequently, the rising incidence of oral cancer stands as a driving force for the growth of the oral cancer treatment market.

Major companies in the oral cancer treatment market are focusing on developing innovative solutions such as CancerDetect to enhance their market profitability. CancerDetect, a screening test for mouth and throat cancer, was launched by Viome Life Sciences Inc. in August 2022. This at-home test aims to detect early-stage oral and throat cancer biomarkers, particularly oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC).

In August 2022, Merck & Co. Inc., a leading pharmaceutical company in oral cancer drug development, collaborated with Orna Therapeutics. This collaboration seeks to accelerate the development of RNA therapies, leveraging the combined expertise of both companies to provide new treatment options for patients. The partnership with Orna Therapeutics aligns with Merck & Co.'s commitment to advancing innovative cancer treatments and improving patient outcomes. Orna Therapeutics, a biotech firm in the United States, specializes in developing treatments for various illnesses, including cancer.

Major companies operating in the oral cancer treatment market report are Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co., AbbVie Inc., Novartis AG, Bayer AG, Sanofi-Aventis LLC, Bristol Myers Squibb, AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG., Viatris Inc., Teva Pharmaceuticals Industries Ltd., MD Anderson Cancer Center, Bausch Health Companies Inc., Memorial Sloan Kettering Cancer Center, Aurobindo Pharma Limited, Cipla Inc., Sun Pharmaceutical Industries Ltd., Lupin Limited, Fred Hutchinson Cancer Research Center, Fresenius Kabi AG, Innovent Biologics Inc., Genentech Inc., Intas Pharmaceuticals Ltd., Ascendis Pharma A/S, Qilu Pharmaceutical Co. Ltd.

North America was the largest region in the oral cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oral cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oral cancer treatment market consists of revenues earned by entities by providing services such as diagnosis and staging, surgical services, radiation therapy, chemotherapy and targeted therapy, immunotherapy, and supportive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral cancer treatment market also includes sales of biopsy tools, imaging equipment, endoscopes, surgical instruments, radiation machines, cisplatin, docetaxel, methotrexate, bleomycin sulfate, and pembrolizumab. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Cancer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral cancer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral cancer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Oral Squamous Cell Carcinoma; Oral Verrucous Carcinoma; Mucoepidermoid Carcinoma; Oral Cavity Lymphomas
• 2) By Therapy Type: Chemotherapy; Radiation Therapy; Biological Therapy
• 3) By Route Of Administration: Oral; Injectable; Other Routes Of Administration
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Oral Squamous Cell Carcinoma: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy
• 2) By Oral Verrucous Carcinoma: Surgical Excision; Radiation Therapy
• 3) By Mucoepidermoid Carcinoma: Surgical Resection; Radiation Therapy; Chemotherapy
• 4) By Oral Cavity Lymphomas: Chemotherapy; Radiation Therapy; Immunotherapy
• Companies Mentioned: Pfizer Inc.; F. Hoffmann La Roche Ltd.; Merck & Co.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oral Cancer Treatment Market Characteristics

3. Oral Cancer Treatment Market Trends And Strategies

4. Oral Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oral Cancer Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oral Cancer Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oral Cancer Treatment Market Growth Rate Analysis
• 5.4. Global Oral Cancer Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oral Cancer Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oral Cancer Treatment Total Addressable Market (TAM)

6. Oral Cancer Treatment Market Segmentation

• 6.1. Global Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Squamous Cell Carcinoma
• Oral Verrucous Carcinoma
• Mucoepidermoid Carcinoma
• Oral Cavity Lymphomas
• 6.2. Global Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiation Therapy
• Biological Therapy
• 6.3. Global Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Other Routes Of Administartions
• 6.4. Global Oral Cancer Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Oral Cancer Treatment Market, Sub-Segmentation Of Oral Squamous Cell Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Chemotherapy
• Targeted Therapy
• 6.6. Global Oral Cancer Treatment Market, Sub-Segmentation Of Oral Verrucous Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Excision
• Radiation Therapy
• 6.7. Global Oral Cancer Treatment Market, Sub-Segmentation Of Mucoepidermoid Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Resection
• Radiation Therapy
• Chemotherapy
• 6.8. Global Oral Cancer Treatment Market, Sub-Segmentation Of Oral Cavity Lymphomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiation Therapy
• Immunotherapy

7. Oral Cancer Treatment Market Regional And Country Analysis

• 7.1. Global Oral Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oral Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Cancer Treatment Market

• 8.1. Asia-Pacific Oral Cancer Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Cancer Treatment Market

• 9.1. China Oral Cancer Treatment Market Overview
• 9.2. China Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Cancer Treatment Market

• 10.1. India Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Cancer Treatment Market

• 11.1. Japan Oral Cancer Treatment Market Overview
• 11.2. Japan Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Cancer Treatment Market

• 12.1. Australia Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Cancer Treatment Market

• 13.1. Indonesia Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Cancer Treatment Market

• 14.1. South Korea Oral Cancer Treatment Market Overview
• 14.2. South Korea Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Cancer Treatment Market

• 15.1. Western Europe Oral Cancer Treatment Market Overview
• 15.2. Western Europe Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Cancer Treatment Market

• 16.1. UK Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Cancer Treatment Market

• 17.1. Germany Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Cancer Treatment Market

• 18.1. France Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Cancer Treatment Market

• 19.1. Italy Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Cancer Treatment Market

• 20.1. Spain Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Cancer Treatment Market

• 21.1. Eastern Europe Oral Cancer Treatment Market Overview
• 21.2. Eastern Europe Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Cancer Treatment Market

• 22.1. Russia Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Cancer Treatment Market

• 23.1. North America Oral Cancer Treatment Market Overview
• 23.2. North America Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Cancer Treatment Market

• 24.1. USA Oral Cancer Treatment Market Overview
• 24.2. USA Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Cancer Treatment Market

• 25.1. Canada Oral Cancer Treatment Market Overview
• 25.2. Canada Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Cancer Treatment Market

• 26.1. South America Oral Cancer Treatment Market Overview
• 26.2. South America Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Cancer Treatment Market

• 27.1. Brazil Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Cancer Treatment Market

• 28.1. Middle East Oral Cancer Treatment Market Overview
• 28.2. Middle East Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Cancer Treatment Market

• 29.1. Africa Oral Cancer Treatment Market Overview
• 29.2. Africa Oral Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oral Cancer Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oral Cancer Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Cancer Treatment Market Competitive Landscape And Company Profiles

• 30.1. Oral Cancer Treatment Market Competitive Landscape
• 30.2. Oral Cancer Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Oral Cancer Treatment Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi-Aventis LLC
• 31.3. Bristol Myers Squibb
• 31.4. AstraZeneca plc
• 31.5. GlaxoSmithKline plc
• 31.6. Eli Lilly and Company
• 31.7. C.H. Boehringer Sohn AG & Co. KG.
• 31.8. Viatris Inc.
• 31.9. Teva Pharmaceuticals Industries Ltd.
• 31.10. MD Anderson Cancer Center
• 31.11. Bausch Health Companies Inc.
• 31.12. Memorial Sloan Kettering Cancer Center
• 31.13. Aurobindo Pharma Limited
• 31.14. Cipla Inc.
• 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Oral Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Cancer Treatment Market

34. Recent Developments In The Oral Cancer Treatment Market

35. Oral Cancer Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Oral Cancer Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oral Cancer Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oral Cancer Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer